Cargando…
LBSAT142 Discovery And Characterization Of A Potent And Orally Bioavailable Parathyroid Hormone Receptor Type-1 (PTHR1) Antagonist For The Treatment Of Hypercalcemia
Hypercalcemia is a common disorder defined as a serum calcium concentration higher than the normal range of 8.5 - 10.5 mg/dL. The most common causes of hypercalcemia are over-secretion of parathyroid hormone (PTH) from one or more enlarged parathyroid glands, which can lead to primary hyperparathyro...
Autores principales: | Rico-Bautista, Elizabeth, Pontillo, Joseph, Wang, Shimiao, Antwan, Agnes S, Arroyo, Pablo, Fleck, Beth, Fowler, Melissa A, Reinhart, Greg, Johns, Michael A, Kusnetzow, Ana K, Zhu, Yun Fei, Markison, Stacy, Betz, Stephen F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629207/ http://dx.doi.org/10.1210/jendso/bvac150.309 |
Ejemplares similares
-
SAT182 Effects Of An Orally Bioavailable Nonpeptide Parathyroid Hormone Receptor Type 1 (PTH1R) Antagonist In Rodent Models Of Primary Hyperparathyroidism (PHPT)
por: Antwan, Agnes S, et al.
Publicado: (2023) -
LBSAT127 An Underrecognized Entity: Hypercalcemia Induced PRES
por: Sari, Esra, et al.
Publicado: (2022) -
LBSAT145 Localizing The "Difficult" Parathyroid Tumor
por: Graf, Akua, et al.
Publicado: (2022) -
LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
por: Agu, Chinyere, et al.
Publicado: (2022) -
SAT-LB63 A Case of PTHrP-Negative Hypercalcemia of Malignancy
por: Murati, Jonila, et al.
Publicado: (2020)